Longevity: Can We Add Another 30 Years? | The Decade Ahead
People are living longer than ever before and the science helping us live healthier for longer is advancing at a rapid pace. From AI-powered drug discovery and personalised medicine to GLP-1s and the longevity economy, this episode explores the trends reshaping healthcare, the companies leading the charge, and how…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Equity Mates Investing Podcast
See all episodes →
68%Replace your salary with dividend income
63%Not all income is created equal with Helen Mason | Schroders
62%Data centre resistance grows, CSL is (sort of) back & a stock picker joins Pimp my Portfolio
Similar episodes from other shows
More like Equity Mates Investing Podcast →
#303: The AI Stocks No One is Talking About: Biotech Boom
Cambrian Biopharma's James Peyer: "70 will be the new 50"
The Longevity Imperative: Redefining the Way We Age
54%Where to find healthy profits in biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.